March 2026 SSANA Data Report

March 2026 SSANA Data Report.

This report captures program activity, outreach, and harm reduction supply distribution for the month, along with cumulative totals for 2026 and a comparison to March 2025.

A few key highlights from March 2026 and year-to-date:

• 58 overdose reversals in March, bringing the 2026 total to 131 lives saved in just the first three months of the year.

• 322 total transactions in March, with 156 unique individuals served, reflecting a significant increase in engagement compared to prior months.

• 716 secondary contacts, continuing to demonstrate strong community reach and peer-to-peer impact.

• 16,980 sterile syringes distributed in March (43,710 year-to-date), alongside a 93% return rate year-to-date, supporting safer use and proper disposal practices.

• 698 safer injection kits distributed in March (1,709 YTD), indicating increased utilization of harm reduction supplies.

• Continued expansion of drug checking and safety tools:

135 fentanyl test kits distributed

110 xylazine test kits distributed

• 322 connections to healthcare, behavioral health, and testing services, reinforcing the program’s role as a critical access point to care.

Compared to March 2025, the data shows continued growth in overdose reversals, service connections, and overall engagement, highlighting both increased need and expanded program capacity.

Important update:

Beginning in March, we have started tracking syringes collected through community clean-up initiatives separately from standard SSP returns. As a result, the return rate reflected in this report does not fully capture all syringes recovered this month, and future reports will provide a more comprehensive picture of total community syringe recovery efforts.

Overall, March reflects a continued upward trend in both service demand and program impact, particularly in overdose prevention and community engagement.